EnGenius Expands Their Cloud-Managed Multi-Gigabit Switching Solution

EnGenius Technologies Inc., a worldwide manufacturer of future-proof enterprise networking solutions, today announced the expansion of its switch line to include 24- and 48-port multi-gigabit switches, capable of powering IP cameras, VoIP phones, and access points commonly found in large business environments.

The EnGenius ECS2528FP and ECS2552FP cloud-managed, PoE+ multi-gigabit switches come with large PoE budgets to power devices on every port, simple network configuration for quick installations in big networks, and secure monitoring and management capabilities from anywhere. The switches also leverage features like extended PoE mode to increase reach and maximize device placement, as well as PD lifeguard and continuous PoE power to ensure uptime for surveillance cameras.

Key Features:

  • Multi-gigabit 24- and 48-port for super-fast speeds
  • 16 GbE / 8 2.5-GbE and 32 GbE / 16 2.5-GbE Ethernet ports
  • 802.3at compliant with PoE budgets of 410 and 740 watts
  • 152 and 224 Gbps capacities for enterprise switching
  • 4 10-gigabit dual-speed SFP+ (fiber) uplink ports for connecting buildings and floors
  • Remote cable testing, ping and Tracert, and MAC table visibility
  • Real-time system metrics, deep-dive analytics, and remote configurations

These new multi-gigabit switches round out the current 8-port multi-gig and 10-gig switch solution so IT professionals can better utilize rack space and offer more flexibility in enterprise networks. EnGenius cloud switches can be simply managed, configured, and troubleshot simultaneously through both the EnGenius Cloud interface and the switch’s local interface. Powerful management and feature-rich switching unite to form the strong backbone of your enterprise network.

More here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.